Pfizer selects Exco InTouch’s novel eDiary technologies to initiate first ever Patient-Centered clinical trial
21 June 2011 | By The Scott Partnership
Exco InTouch, announced that its novel eDiary technologies have been selected by Pfizer...
List view / Grid view
News
ERT appoints Robert Kleiman MD to Chief Medical Officer
21 June 2011 | By ERT
ERT, announced that Robert Kleiman, has been appointed to the role of Chief Medical Officer...
FDA panel endorses efficacy but not safety of Novartis drug ACZ885 for gouty arthritis
21 June 2011 | By Novartis
FDA panel voted in favor of the overall efficacy but not the overall safety of ACZ885...
Pfizer’s Lyrica top-line results positive in global Phase 3 Study
21 June 2011 | By Pfizer
Pfizer Inc. announced that top-line results for Lyrica Study A0081107, demonstrated that the study met its primary endpoint...
Thermo Fisher Scientific introduces expanded chromatography portfolio
Thermo Fisher Scientific Inc., the world leader in serving science, today announced it will show its expanded portfolio of market-leading chromatography solutions within the Thermo Scientific and Dionex booths at HPLC 2011, a first since Thermo Fisher acquired Dionex.
Abbott receives FDA approval for a new six-month formulation of Lupron Depot®
20 June 2011 | By Abbott
"Lupron Depot is an important treatment option for many patients..."
Hudson Robotics announces its new fully automated colony isolation workcell
20 June 2011 | By Hudson Robotics
First successful installation of its newest RapidPick™ Workcell System...
Boehringer Ingelheim extends “one stop shop” service
20 June 2011 | By Boehringer Ingelheim
To round off its full-service capabilities for clients, Boehringer Ingelheim is expanding its capacities and capabilities in fill & finish for biopharmaceuticals at their state-of-the-art facility in Biberach, Germany, with a new filling line.
Pivotal study showed vismodegib helped shrink skin cancer tumours
20 June 2011 | By Roche
Pivotal Phase II study with vismodegib showed positive results in people with advanced advanced basal cell carcinoma.
Pfizer and Acura announce FDA Approval of Oxectatm (Oxycodone HCL, USP) CII
20 June 2011 | By Pfizer
Pfizer Inc. and Acura Pharmaceuticals Inc., announce the marketing approval from the U.S. FDA of OXECTATM (oxycodone HCl, USP) Tablets CII...
New data confirm superior blood pressure reductions in diabetic patients treated with TWYNSTA®
17 June 2011 | By Boehringer Ingelheim
TWYNSTA® leads to prompt and very effective reductions in blood pressure...
Novartis begins construction of new state-of-the-art pharmaceutical manufacturing plant
16 June 2011 | By Novartis
Construction of this facility represents the most significant Novartis investment in Russia...
Sanofi enters into research collaboration with Audion Therapeutics
16 June 2011 | By Sanofi
Sanofi has entered into a research collaboration with Audion Therapeutics to develop potential treatments for hearing loss...
Greenphire Partners with Mytrus to provide web-based solutions
16 June 2011 | By The Scott Partnership
Greenphire, partners with Mytrus to deliver novel and efficient web-based solutions for clinical trial patients...
Novartis application for expanded Menveo® indication from 2 months of age accepted for review by FDA
16 June 2011 | By Novartis
The US FDA has accepted for review its supplemental Biologics License Application...
